| abstract |
The present invention relates to novel sulfonamide derivatives of the general formula (Ia, Ib, Ic), optionally in the form of their stereoisomers, preferably one of the enantiomers or diastereomers, their racemates Or their stereoisomers in any mixing ratio, preferably in the form of at least two mixtures of enantiomers or diastereomers, or salts thereof, preferably the corresponding physiologically acceptable salts Or their corresponding solvates, as well as their methods of preparation, their use in pharmaceuticals for human and / or veterinary treatment, and pharmaceutical compositions containing them. |